A real-time PCR approach based on SPF10 primers and the INNO-LiPA HPV Genotyping Extra assay for the detection and typing of human papillomavirus

Journal of Virological Methods

Volumn 187, Issue 1, 2013, Pages 166-171

  Micalessi, M I ^a   Boulet, G A ^a   Vorsters, A ^a   De Wit, K ^a   Jannes, G ^b   Mijs, W ^b   Ieven, M ^a   Van Damme, P ^a   Bogers, J J ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b INNOGENETICS   (Belgium)

Author keywords

Genotype; Human papillomavirus; LiPA; Real time PCR; SPF10

Indexed keywords

VIRUS DNA;

AMPLICON; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC TEST ACCURACY STUDY; GENE AMPLIFICATION; GENOTYPING TECHNIQUE; HUMAN PAPILLOMAVIRUS DNA TEST; LIMIT OF DETECTION; MIXED INFECTION; NONHUMAN; PAPILLOMAVIRUS INFECTION; PLASMID; PREDICTIVE VALUE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TEMPERATURE; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

HUMAN PAPILLOMAVIRUS;

EID: 85027945233     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.09.013     Document Type: Article

References (14)

1. Bosch F.X., Lorincz A., Muñoz N., Meijer C.J., Shah K.V. The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology 2002, 55:244-265.
2. Boulet G.A., Horvath C.A., Berghmans S., Bogers J. Human papillomavirus in cervical cancer screening: important role as biomarker. Cancer Epidemiology, Biomarkers and Prevention 2008, 17:810-817.
3. Cuschieri K.S., Whitley M.J., Cubie H.A. Human papillomavirus type specific DNA and RNA persistence-implications for cervical disease progression and monitoring. Journal of Medical Virology 2004, 73:65-70.
4. Cuzick J., Arbyn M., Sankaranarayanan R., Tsu V., Ronco G., Mayrand M.H., Dillner J., Meijer C.J. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008, 26:K29-K41.
5. Dal Bello B., Spinillo A., Alberizzi P., Cesari S., Gardella B., Silini E.M. Time trends of human papillomavirus type distribution in Italian women with cervical intraepithelial neoplasia (CIN). Gynecologic Oncology 2009, 115:262-266.
6. Gravitt P.E., Coutlée F., Iftner T., Sellors J.W., Quint W.G., Wheeler C.M. New technologies in cervical cancer screening. Vaccine 2008, 26:K42-K52.
7. Karsai A., Müller S., Platz S., Hauser M.T. Evaluation of a homemade SYBR green I reaction mixture for real-time PCR quantification of gene expression. Biotechniques 2002, 32(790-2):794-796.
8. Kleter B., van Doorn L.J., Ter Schegget J., Schrauwen L., van Krimpen K., Burger M., ter Harmsel B., Quint W. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. American Journal of Pathology 1998, 153:1731-1739.
9. Kleter B., van Doorn L.J., Schrauwen L., Molijn A., Sastrowijoto S., ter Schegget J., Lindeman J., ter Harmsel B., Burger M., Quint W. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. Journal of Clinical Microbiology 1999, 37:2508-2517.
10. m) of herpes simplex virus (HSV) hybridization probes. Journal of Virological Methods 2008, 151:158-160.
11. Longo M.C., Berninger M.S., Hartley J.L. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 1990, 93:125-128.
12. Payan C., Ducancelle A., Aboubaker M.H., Caer J., Tapia M., Chauvin A., Peyronnet D., Le Hen E., Arab Z., Legrand M.C., Tran A., Postec E., Tourmen F., Avenel M., Malbois C., De Brux M.A., Descamps P., Lunel F. Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems. Journal of Clinical Microbiology 2007, 45:897-901.
13. Perrons C., Jelley R., Kleter B., Quint W., Brink N. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA. Journal of Clinical Virology 2005, 32:278-285.
14. Smits P.H., Bakker R., Jong E., Mulder J.W., Meenhorst P.L., Kleter B., van Doorn L.J., Quint W.G. High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men. Journal of Clinical Microbiology 2005, 43:5936-5939.